NewsRoom Articles - Page 1326 of 1335

FridayAug 26, 2016 2:58 pm

ViaSat, Inc. (VSAT) Awarded SPAWAR Contract to Support Modernization of UHF Satellite Communications System

In a recent news release, ViaSat, Inc. (NASDAQ: VSAT), a world leader in ultra high frequency (UHF) satellite communications for defense organizations, announced that it has been awarded a sole source contract from the Space and Naval Warfare Systems Command (“SPAWAR”) for engineering, technical services and hardware/software products in support of the U.S. Navy’s joint UHF military satellite communications (satcom) system. Per the terms of the contract, ViaSat will contribute to the ongoing sustainment and modernization of the joint UHF military satcom network integrated control system, UHF satcom channel controls and user terminals, playing a key role in the U.S.…

FridayAug 26, 2016 1:07 pm

Dehaier Medical Systems (DHRM) Capitalizes on its Focus Shift to mHealth via Strategic $20M Deal

According to a report published late last year by MarketsandMarkets (http://nnw.fm/3tgzS), the global mHealth (mobile health) solutions market is on track to hit upward of $59 billion by 2020, growing at a CAGR of around 33.4 percent. Some of the most obvious drivers here are mobile device (as well as 3G/4G network) proliferation/penetration rates, the accelerating transition to outcomes-based and patient-centric healthcare delivery and the rapidly mounting utilization of connected mobile devices within global healthcare systems in order to better manage/reduce costs associated with chronic diseases. One place this continuum of drivers is particularly evident is in the world’s largest…

FridayAug 26, 2016 12:19 pm

Laguna Blends, Inc. (CSE: LAG) (OTC: LAGBF) (LB6A.F) Announces Closing of First Tranche of Private Placement

Before the opening bell, Laguna Blends, Inc. (CSE: LAG) (OTC: LAGBF) (FRANKFURT: LB6A.F) announced a first tranche closing related to its non-brokered private placement. The first tranche closing included the issuance of 1,627,200 units at a price of $0.25 per unit for gross proceeds of $406,800. Each of these units includes one common share, as well as a purchase warrant entitling the holder to acquire an additional common share of Laguna’s stock at a price of $0.40, valid until August 25, 2017. Securities issued as part of the first tranche will be subject to a hold period expiring four months…

ThursdayAug 25, 2016 2:24 pm

Versartis, Inc. (VSAR) Completes Enrollment in Phase III VELOCITY Trial of Somavaratan for the Treatment of Pediatric GHD

In a recent news release, Versartis, Inc. (NASDAQ: VSAR), an endocrine-focused biopharmaceutical company, announced the completion of enrollment for its phase III VELOCITY trial of somavaratan, a long-acting form of recombinant human growth hormone (rhGH) currently being evaluated for the treatment of pediatric growth hormone deficiency (GHD). The randomized, open-label registration trial will focus on pre-pubertal children with GHD who are naïve to treatment. Moving forward, the 137 enrolled patients will be followed for the primary trial endpoint of height velocity at 12 months, along with safety and pharmacodynamics secondary endpoints. Versartis expects to present top-line results from the VELOCITY…

ThursdayAug 25, 2016 1:06 pm

eXp World Holdings’ (EXPI) Agent-Owned Cloud Brokerage Offers a New Deal as New Home Sales Keep Rising

eXp World Holdings, Inc. (OTCQB: EXPI) is offering Americans a 21st century new deal with its Agent-Owned Cloud Brokerage™. Back in the 1930s, Americans were, as they have been in recent times, picking up the pieces after a series of devastating economic events, but if we thought the Great Recession was bad, it’s because most of us haven’t been around long enough to remember the Great Depression. Writing in the Wall Street Journal (http://nnw.fm/Diys5), well-known financial commentator and hedge fund director Roger Lowenstein opined that ‘the world didn’t experience anything close to a global depression during the recent crisis. Peak…

ThursdayAug 25, 2016 12:33 pm

Pluristem Therapeutics, Inc. (PSTI) Secures $8 Million EU Grant for Critical Limb Ischemia Study

Pluristem Therapeutics, Inc. (NASDAQ: PSTI), a leading Israel-based developer of placenta cell therapies for various ailments including ischemia, inflammation, radiation damage and hematology disorders, recently secured an $8 million grant from the European Union for its critical limb ischemia (CLI) program, according to a news release (http://nnw.fm/YvNo5) issued August 9. The CLI grant, offered under the EU’s largest research and innovation program, Horizon 2020, will cover a significant portion of Pluristem’s PLacental eXpanded (PLX) PAD cells study, which will enroll about 250 U.S. and European patients suffering from CLI Rutherford Category 5. This category of patients is commonly unsuitable for…

WednesdayAug 24, 2016 3:57 pm

Dynasil Corporation of America (DYSL) Subsidiary Receives $1.86 Million in Grants from U.S. Department of Energy

In a recent news release, Dynasil Corporation of America (NASDAQ: DYSL) announced that RMD, Inc., its contract research subsidiary, has been awarded two phase II grants totaling $1.86 million under the U.S. Department of Energy’s Small Business Innovative Research (SBIR) and Small Business Technology Transfer (STTR) programs. The SBIR program is designed to help domestic small businesses explore their technological potential by encouraging them to engage in federal research and development that has the potential for commercialization, while the STTR program aims to bridge the gap between performance of basic science and commercialization of resulting innovations. Funding stemming from the…

WednesdayAug 24, 2016 2:30 pm

Medical Transcription Billing Corp. (MTBC) (MTBCP) Full-Spectrum Web EHR & Services Platform Poised to Pop as Healthcare IT Market Booms

A recent report (http://nnw.fm/K8iRV) on the global Healthcare IT (HIT) market from Technavio projects an attractive seven percent CAGR for the space over the next four years, when the U.S. sector alone will generate upwards of $75 billion annually. The analysts at MarketsandMarkets affirmed this outlook in their report on the sector late last year (http://nnw.fm/UO9j8), projecting that the global healthcare IT market will see a CAGR nearly twice the Technavio figure when all sources are accounted for, coming to represent a total market valued at somewhere in the neighborhood of $228 billion by 2020. The biggest names in the…

WednesdayAug 24, 2016 1:28 pm

eXp World Holdings, Inc. (EXPI) Subject of Updated Research Report by Fundamental Research Corp.

Yesterday, Fundamental Research Corp., an independent research firm specializing in the small-cap and microcap sectors, announced the release of an updated analysis on eXp World Holdings, Inc. (OTCQB: EXPI). The new analysis, which includes upward revisions from Fundamental Research Corp.’s original report released in April of this year, highlights EXPI’s strong fiscal performance in the second quarter of 2016, healthy balance sheet and recent independent additions to its board of directors as reasons prospective investors may want to take a second look at the company. “We are raising our revenue forecast for 2016 from $40.50 million to $48.94 million, and…

WednesdayAug 24, 2016 9:37 am

Monaker Group, Inc. (MKGI) Set to Expand Industry Partnerships with Launch of Monaker Booking Engine

Before the opening bell, Monaker Group, Inc. (OTCQB: MKGI) announced completion of the design, architecture and buildout of its Application Program Interface (“API”) and the corresponding launch of its Monaker Booking Engine (“MBE”). This announcement marks a key milestone in the company’s efforts to develop a sustainable foothold in the rapidly growing alternative lodging space, as the completed API and MBE will allow Monaker to work toward partnering with large, established online travel agencies, tour operators, airlines and cruise originators to offer its sizable inventory in a real-time booking format. This real-time booking format is key to the company’s future…

Financial news and publishing for public and private companies

Contact us: 512.354.7000